Dayvigo

Dayvigo is a prescription medication containing Lemborexant, an advanced dual orexin receptor antagonist (DORA) used in the management of insomnia. Developed by Eisai Pharmaceuticals India Pvt Ltd, Dayvigo is available in 5mg and 10mg strengths, supplied in a 14-tablet blister pack. Its unique mechanism helps regulate the sleep–wake cycle, making it a modern alternative to traditional hypnotics.

💊 Product Overview

🔬 How Dayvigo Works

Lemborexant works by selectively blocking orexin receptors (OX1R and OX2R) in the brain. Orexin neuropeptides play a key role in wakefulness. By inhibiting these receptors, Dayvigo reduces overactive wake signals, helping patients fall asleep faster and stay asleep longer, without causing the heavy sedation often seen in benzodiazepines or Z-drugs.

⚕️ Indications & Benefits

• Treatment of chronic or transient insomnia.

• Improves both sleep onset latency and sleep maintenance.

• Reduces night-time awakenings.

• Promotes restorative and natural sleep patterns.

• Lower risk of dependence compared to traditional hypnotics.

📦 Available Variants

• Dayvigo 5mg Tablets – for patients starting therapy or requiring lower doses.

• Dayvigo 10mg Tablets – for patients needing stronger therapeutic effect.

🌍 Global Availability

Dayvigo (Lemborexant) has regulatory approval in multiple countries, including:

• USA – FDA approved in 2019.

• Japan & EU – Widely prescribed for insomnia management.

• India – Marketed by Eisai Pharmaceuticals India Pvt Ltd.

This makes it accessible to patients in US, UK, Australia, Europe, and Asia via licensed pharmacies.

⚠️ Safety Information

• Should be taken immediately before bedtime.

• Avoid alcohol or CNS depressants while on Dayvigo.

• Possible side effects: somnolence, headache, fatigue, abnormal dreams.

• Caution in elderly patients due to increased fall risk.

• Contraindicated in narcolepsy.

🔗 Related Products & Alternatives

• [Qutipin (Quetiapine) – Sun Pharma]